These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 25749381

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP, Zeng XC, Zhang B, Long JT, Zhou B, Tan GS, Zeng WX, Chen W, Yang JY.
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [Abstract] [Full Text] [Related]

  • 3. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
    Zhou JD, Shen F, Ji JS, Zheng K, Huang M, Wu JC.
    Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
    [Abstract] [Full Text] [Related]

  • 4. Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.
    Fang T, Cui M, Sun J, Ge C, Zhao F, Zhang L, Tian H, Zhang L, Chen T, Jiang G, Xie H, Cui Y, Yao M, Li H, Li J.
    Oncotarget; 2015 Jun 30; 6(18):16106-19. PubMed ID: 25965830
    [Abstract] [Full Text] [Related]

  • 5. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Lei X, Li YF, Chen GD, Ou DP, Qiu XX, Zuo CH, Yang LY.
    Oncotarget; 2015 Dec 01; 6(38):40622-41. PubMed ID: 26536663
    [Abstract] [Full Text] [Related]

  • 6. Enhanced NOLC1 promotes cell senescence and represses hepatocellular carcinoma cell proliferation by disturbing the organization of nucleolus.
    Yuan F, Zhang Y, Ma L, Cheng Q, Li G, Tong T.
    Aging Cell; 2017 Aug 01; 16(4):726-737. PubMed ID: 28493459
    [Abstract] [Full Text] [Related]

  • 7. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
    Pannem RR, Dorn C, Ahlqvist K, Bosserhoff AK, Hellerbrand C, Massoumi R.
    Carcinogenesis; 2014 Feb 01; 35(2):461-8. PubMed ID: 24104553
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression.
    Li GQ, Guo WZ, Zhang Y, Seng JJ, Zhang HP, Ma XX, Zhang G, Li J, Yan B, Tang HW, Li SS, Wang LD, Zhang SJ.
    Oncotarget; 2016 Jan 19; 7(3):2462-74. PubMed ID: 26575167
    [Abstract] [Full Text] [Related]

  • 11. CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.
    Pu H, Zheng Q, Li H, Wu M, An J, Gui X, Li T, Lu D.
    Oncotarget; 2015 Dec 01; 6(38):40775-98. PubMed ID: 26513297
    [Abstract] [Full Text] [Related]

  • 12. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
    Wang F, Feng Y, Li P, Wang K, Feng L, Liu YF, Huang H, Guo YB, Mao QS, Xue WJ.
    Oncotarget; 2016 Jan 26; 7(4):4279-97. PubMed ID: 26701853
    [Abstract] [Full Text] [Related]

  • 13. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
    Yin J, Ding J, Huang L, Tian X, Shi X, Zhi L, Song J, Zhang Y, Gao X, Yao Z, Jing X, Yang J.
    Anat Rec (Hoboken); 2013 Oct 26; 296(10):1568-75. PubMed ID: 23878061
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma.
    Shen G, Rong X, Zhao J, Yang X, Li H, Jiang H, Zhou Q, Ji T, Huang S, Zhang J, Jia H.
    Carcinogenesis; 2014 Dec 26; 35(12):2748-55. PubMed ID: 25280563
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
    Mansour MA, Hyodo T, Akter KA, Kokuryo T, Uehara K, Nagino M, Senga T.
    Oncotarget; 2016 Jan 26; 7(4):4993-5006. PubMed ID: 26701851
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the GNMT-HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma.
    Li CH, Yen CH, Chen YF, Lee KJ, Fang CC, Zhang X, Lai CC, Huang SF, Lin HK, Arthur Chen YM.
    Int J Cancer; 2017 May 15; 140(10):2284-2297. PubMed ID: 28205209
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein.
    Dong C, Zhao B, Long F, Liu Y, Liu Z, Li S, Yang X, Sun D, Wang H, Liu Q, Liang R, Li Y, Gao Z, Shao S, Miao QR, Wang L.
    Oncotarget; 2016 Feb 23; 7(8):8850-65. PubMed ID: 26840457
    [Abstract] [Full Text] [Related]

  • 20. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I, Pinyol R, Dauch D, Torrecilla S, Tovar V, Moeini A, Alsinet C, Portela A, Rodriguez-Carunchio L, Solé M, Lujambio A, Villanueva A, Thung S, Esteller M, Zender L, Llovet JM.
    Gastroenterology; 2016 Dec 23; 151(6):1192-1205. PubMed ID: 27614046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.